Abstract
Dopamine receptors were examined by Scatchard analysis in the striatal and olfactory tubercle regions of 11 inbred mouse strains. Simultaneous determinations of the binding characteristics of 3H-labeled 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN), a dopaminergic agonist, and [3H]spiroperidol, a dopaminergic antagonist, were examined. Among the 11 strains, the equilibrium dissociation constant (Kd) for agonist binding did not vary in either the striatum or the olfactory tubercle. Similarly, no strain differences were observed in the Kd for spiroperidol in either region, although the Kd for spiroperidol in the olfactory tubercle was uniformly higher than that in the striatum. Measurement of receptor concentrations revealed strain differences of up to 2-fold for both [3H]ADTN and [3H]spiroperidol binding sites. Within each brain region, the densities of agonist and antagonist binding sites correlated significantly. However, between brain regions there was no correlation in the density of agonist or antagonist binding sites, which suggests that mesolimbic and nigrostriatal dopamine neurons may be under independent genetic control. Analysis of [3H]spiroperidol displacement by clofluperol, aceperone, cinanserin, and mianserin in four inbred mouse strains revealed that 88-90% of the striatal spiroperidol sites are dopaminergic, with the remainder being serotonergic. In contrast, 53-66% of the olfactory tubercle [3H]spiroperidol binding sites are dopaminergic and 34-47% are serotonergic. These data suggest that genetic differences in serotonin receptors and dopamine receptors may exist among inbred mouse strains.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baker H., Joh T. H., Reis D. J. Genetic control of number of midbrain dopaminergic neurons in inbred strains of mice: relationship to size and neuronal density of the striatum. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4369–4373. doi: 10.1073/pnas.77.7.4369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Creese I., Burt D. R., Snyder S. H. Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol. Life Sci. 1975 Sep 15;17(6):933–1001. doi: 10.1016/0024-3205(75)90454-3. [DOI] [PubMed] [Google Scholar]
- Creese I., Usdin T., Snyder S. H. Guanine nucleotides distinguish between two dopamine receptors. Nature. 1979 Apr 5;278(5704):577–578. doi: 10.1038/278577a0. [DOI] [PubMed] [Google Scholar]
- Kety S. S., Rosenthal D., Wender P. H., Schulsinger F., Jacobsen B. Mental illness in the biological and adoptive families of adopted individuals who have become schizophrenic. Behav Genet. 1976 Jul;6(3):219–225. doi: 10.1007/BF01065721. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Leysen J. E., Gommeren W. Different kinetic properties of neuroleptic receptor binding in the rat striatum and frontal cortex. Life Sci. 1978 Aug 7;23(5):447–452. doi: 10.1016/0024-3205(78)90151-0. [DOI] [PubMed] [Google Scholar]
- Peroutka S. J., Snyder S. H. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol. 1979 Nov;16(3):687–699. [PubMed] [Google Scholar]